-
1
-
-
78149469728
-
Chaperone-mediated autophagy markers in Parkinson disease brains
-
Alvarez-Erviti L, Rodriguez-Oroz MC, Cooper JM, Caballero C, Ferrer I, Obeso JA et al (2010) Chaperone-mediated autophagy markers in Parkinson disease brains. Arch Neurol 67(12):1464-1472
-
(2010)
Arch Neurol
, vol.67
, Issue.12
, pp. 1464-1472
-
-
Alvarez-Erviti, L.1
Rodriguez-Oroz, M.C.2
Cooper, J.M.3
Caballero, C.4
Ferrer, I.5
Obeso, J.A.6
-
2
-
-
0028091176
-
Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease
-
Dexter DT et al (1994) Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease. Ann Neurol 35:38-44 (Pubitemid 24027604)
-
(1994)
Annals of Neurology
, vol.35
, Issue.1
, pp. 38-44
-
-
Dexter, D.T.1
Sian, J.2
Rose, S.3
Hindmarsh, J.G.4
Mann, V.M.5
Cooper, J.M.6
Wells, F.R.7
Daniel, S.E.8
Lees, A.J.9
Schapira, A.H.V.10
Jenner, P.11
Marsden, C.D.12
-
3
-
-
61649088435
-
PINK1-associated Parkinson's disease is caused by neuronal vulnerability to calcium-induced cell death
-
Gandhi S et al (2009) PINK1-associated Parkinson's disease is caused by neuronal vulnerability to calcium-induced cell death. Mol Cell 33:627-638
-
(2009)
Mol Cell
, vol.33
, pp. 627-638
-
-
Gandhi, S.1
-
4
-
-
61949269129
-
Genomic and proteomic biomarkers for Parkinson disease
-
Gasser T (2009) Genomic and proteomic biomarkers for Parkinson disease. Neurology 72:S27-S31
-
(2009)
Neurology
, vol.72
-
-
Gasser, T.1
-
5
-
-
62749113469
-
Silencing of PINK1 expression affects mitochondrial DNA and oxidative phosphorylation in dopaminergic cells
-
Gegg ME, Cooper JM, Schapira AH, Taanman JW (2009) Silencing of PINK1 expression affects mitochondrial DNA and oxidative phosphorylation in dopaminergic cells. PLoS One 4:e4756
-
(2009)
PLoS One
, vol.4
-
-
Gegg, M.E.1
Cooper, J.M.2
Schapira, A.H.3
Taanman, J.W.4
-
6
-
-
68549136513
-
Differential effects of PINK1 nonsense and missense mutations on mitochondrial function and morphology
-
Grunewald A et al (2009) Differential effects of PINK1 nonsense and missense mutations on mitochondrial function and morphology. Exp Neurol 219:266-273
-
(2009)
Exp Neurol
, vol.219
, pp. 266-273
-
-
Grunewald, A.1
-
8
-
-
67651160657
-
Neuroprotection trials in Parkinson's disease: Systematic review
-
Hart RG, Pearce LA, Ravina BM, Yaltho TC, Marler JR (2009) Neuroprotection trials in Parkinson's disease: systematic review. Mov Disord 24:647-654
-
(2009)
Mov Disord
, vol.24
, pp. 647-654
-
-
Hart, R.G.1
Pearce, L.A.2
Ravina, B.M.3
Yaltho, T.C.4
Marler, J.R.5
-
9
-
-
50049104725
-
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: A case-control study
-
Healy DG et al (2008) Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study. Lancet Neurol 7:583-590
-
(2008)
Lancet Neurol
, vol.7
, pp. 583-590
-
-
Healy, D.G.1
-
10
-
-
62549133546
-
Neuroinflammation in Parkinson's disease: A target for neuroprotection?
-
Hirsch EC, Hunot S (2009) Neuroinflammation in Parkinson's disease: a target for neuroprotection? Lancet Neurol 8:382-397
-
(2009)
Lancet Neurol
, vol.8
, pp. 382-397
-
-
Hirsch, E.C.1
Hunot, S.2
-
11
-
-
33847652900
-
Autophagy and neurodegeneration: When the cleaning crew goes on strike
-
DOI 10.1016/S1474-4422(07)70076-5, PII S1474442207700765
-
Martinez-Vicente M, Cuervo AM (2007) Autophagy and neurodegeneration: when the cleaning crew goes on strike. Lancet Neurol 6:352-361 (Pubitemid 46367949)
-
(2007)
Lancet Neurology
, vol.6
, Issue.4
, pp. 352-361
-
-
Martinez-Vicente, M.1
Cuervo, A.M.2
-
12
-
-
77953666757
-
Parkinson's disease mutations in PINK1 result in decreased Complex I activity and deficient synaptic function
-
Morais VA et al (2009) Parkinson's disease mutations in PINK1 result in decreased Complex I activity and deficient synaptic function. EMBO Mol Med 1:99-111
-
(2009)
EMBO Mol Med
, vol.1
, pp. 99-111
-
-
Morais, V.A.1
-
13
-
-
58149314211
-
Parkin is recruited selectively to impaired mitochondria and promotes their autophagy
-
Narendra D, Tanaka A, Suen DF, Youle RJ (2008) Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol 183:795-803
-
(2008)
J Cell Biol
, vol.183
, pp. 795-803
-
-
Narendra, D.1
Tanaka, A.2
Suen, D.F.3
Youle, R.J.4
-
14
-
-
58349122472
-
Why have we failed to achieve neuroprotection in Parkinson's disease?
-
Olanow CW, Kieburtz K, Schapira AH (2008) Why have we failed to achieve neuroprotection in Parkinson's disease? Ann. Neurol 64:S101-S110
-
(2008)
Ann. Neurol
, vol.64
-
-
Olanow, C.W.1
Kieburtz, K.2
Schapira, A.H.3
-
15
-
-
41549114279
-
The role of autophagylysosome pathway in neurodegeneration associated with Parkinson's disease
-
Pan T, Kondo S, Le W, Jankovic J (2008) The role of autophagylysosome pathway in neurodegeneration associated with Parkinson's disease. Brain 131:1969-1978
-
(2008)
Brain
, vol.131
, pp. 1969-1978
-
-
Pan, T.1
Kondo, S.2
Le, W.3
Jankovic, J.4
-
16
-
-
33750363298
-
The roles of intracellular protein-degradation pathways in neurodegeneration
-
DOI 10.1038/nature05291, PII NATURE05291
-
Rubinsztein DC (2006) The roles of intracellular protein-degradation pathways in neurodegeneration. Nature 443:780-786 (Pubitemid 44622682)
-
(2006)
Nature
, vol.443
, Issue.7113
, pp. 780-786
-
-
Rubinsztein, D.C.1
-
17
-
-
0033616458
-
Science, medicine and the future: Parkinson's disease
-
Schapira AH (1999) Science, medicine, and the future: Parkinson's disease. BMJ 318:311-314 (Pubitemid 29195142)
-
(1999)
British Medical Journal
, vol.318
, Issue.7179
, pp. 311-314
-
-
Schapira, A.H.V.1
-
18
-
-
33744982893
-
Etiology of Parkinson's disease
-
Schapira AH (2006) Etiology of Parkinson's disease. Neurology 66:S10-S23
-
(2006)
Neurology
, vol.66
-
-
Schapira, A.H.1
-
19
-
-
37049004489
-
Mitochondria in the aetiology and pathogenesis of Parkinson's disease
-
DOI 10.1016/S1474-4422(07)70327-7, PII S1474442207703277
-
Schapira AH (2008) Mitochondria in the aetiology and pathogenesis of Parkinson's disease. Lancet Neurol 7:97-109 (Pubitemid 350251942)
-
(2008)
The Lancet Neurology
, vol.7
, Issue.1
, pp. 97-109
-
-
Schapira, A.H.1
-
20
-
-
58149131277
-
Neurobiology and treatment of Parkinson's disease
-
Schapira AH (2009a) Neurobiology and treatment of Parkinson's disease. Trends Pharmacol Sci 30:41-47
-
(2009)
Trends Pharmacol Sci
, vol.30
, pp. 41-47
-
-
Schapira, A.H.1
-
21
-
-
61949458087
-
Molecular and clinical pathways to neuroprotection of dopaminergic drugs in Parkinson disease
-
Schapira AH (2009b) Molecular and clinical pathways to neuroprotection of dopaminergic drugs in Parkinson disease. Neurology 72:S44-S50
-
(2009)
Neurology
, vol.72
-
-
Schapira, A.H.1
-
23
-
-
70349235644
-
Perspectives on recent advances in the understanding and treatment of Parkinson's disease
-
Schapira AH et al (2009) Perspectives on recent advances in the understanding and treatment of Parkinson's disease. Eur J Neurol 16:1090-1099
-
(2009)
Eur J Neurol
, vol.16
, pp. 1090-1099
-
-
Schapira, A.H.1
-
24
-
-
70350319531
-
Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease
-
Sidrasky et al (2009) Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med 361:1651-1661
-
(2009)
N Engl J Med
, vol.361
, pp. 1651-1661
-
-
Sidrasky1
-
25
-
-
0037379324
-
Genetic and environmental factors in the cause of Parkinson's disease
-
Warner TT, Schapira AH (2003) Genetic and environmental factors in the cause of Parkinson's disease. Ann Neurol 53(Suppl 3):S16-S23
-
(2003)
Ann Neurol
, vol.53
, Issue.3 SUPPL.
-
-
Warner, T.T.1
Schapira, A.H.2
|